EPO Releases New European Research Patent Metrics
A new study reveals that European university patents lapse at a significantly higher rate than their US-based counterparts.
Updated on Oct. 25, 2026 in Biotech
Live Poll
Should European universities prioritize commercializing research breakthroughs to boost economic growth and innovation?
The European Patent Office has released a benchmarking study analyzing 809 technology transfer offices, alongside a new data dashboard for tracking public research patent activity. The findings highlight significant scale disparities and high patent lapse rates among European universities compared to their US counterparts.
Why it matters
Accelerating the movement of research breakthroughs from lab to market is critical for regional economic growth and strategic autonomy. This study identifies six specific priorities for scaling the expertise and infrastructure needed to turn academic patents into viable commercial products.
Large-scale technology transfer offices report nearly 16 times more invention disclosures than small or mid-scale counterparts, which comprise 90.5% of the 809 institutions analyzed. While public research organizations drove 8,000 patent applications in 2025, up from 3,200 in 2006, these represent only 9% of all European patents.
The players
European Patent Office
The intergovernmental organization responsible for examining and granting patents across its member states.
CNRS
A leading French national public research organization that serves as a major source of European patent filings.
Fraunhofer-Gesellschaft
A major German research institution focused on applied sciences and industrial technology transfer.
imec
A prominent Belgian research center specializing in nanoelectronics and digital technology.
The details
The European Patent Office combined patent filing metadata with survey data to evaluate institutional capacity. The study identifies that most transfer offices, which handle the process of moving intellectual property from research institutions to the private sector, currently lack the scale to maintain full-suite commercialization expertise in-house. This bottleneck is most visible in biotechnology, where research institutions accounted for 34% of all European-origin applications in 2025.
Timeline
2006: 3,200 patent applications involved public research organizations.
2025: 8,000 patent applications involved public research organizations.
October 25, 2026: European Patent Office study and dashboard released.
The Tech Race
This study updates the historical trajectory of research-backed patenting since the 2006 baseline, showing a sustained increase in volume. It frames the current competitive landscape by highlighting how European institutions compare against U.S. university patent retention benchmarks.
Academic researchers and commercialization leads can now utilize the new Data Desk dashboard to benchmark their institution’s patent activity against regional peers. These insights provide a quantitative basis for institutions to re-evaluate their internal technology transfer resource allocation and staffing.
The takeaway
The widening gap between European and American patent lapse rates suggests that managing the post-filing lifecycle is as crucial as the initial discovery. Interested parties should monitor how institutions adjust their transfer office size and staffing in response to the six priorities identified in this study.
Further reading
Explore deeper insights into institutional innovation in the Biotech section.
Source note: This article includes information reported by Agip-news.
Live Poll
Should European universities prioritize commercializing research breakthroughs to boost economic growth and innovation?
